MSCs

BIOLOGICAL14 trials

Sponsors

Nanfang Hospital, Southern Medical University, Chinese PLA General Hospital, Universidad del Desarrollo, Universidad Autónoma de Bucaramanga, Heba Mohamed Saad Eldien

Conditions

Acute Graft-versus-host DiseaseAtrophic ScarBronchiolitis ObliteransCMV InfectionCOVID-19Delayed Platelet EngraftmentDiabetic Kidney Disease (DKD)Foot Ulcer, Diabetic

Phase 1

MSC for Treatment of Interstitial Lung Disease After Allo-HSCT

Nanfang Hospital, Southern Medical UniversityBronchiolitis Obliterans, Hematopoietic Stem Cell Transplantation, Lung Diseases, Interstitial

Start: 2014-09-30End: 2018-06-30Target: 60Updated: 2017-05-10

MSCs Source of Sweat Gland Cells of Large Area Skin Injury Patients Transplant of the Wound

CompletedNCT02669199

Chinese PLA General HospitalMSCs

Start: 2012-01-31End: 2015-12-31Updated: 2016-02-01

Mesenchymal Stromal Cell Derivatives in the Treatment of Chronic Diabetic Foot Ulcers Type 1 and 2

Universidad Autónoma de BucaramangaFoot Ulcer, Diabetic

Start: 2017-01-31End: 2019-01-31Target: 51Updated: 2016-10-24

Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With COVID-19

Beijing 302 HospitalCOVID-19

Start: 2020-01-27End: 2021-12-31Target: 20Updated: 2020-04-15

Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis

Active, not recruitingNCT04749667

Haukeland University HospitalMultiple Sclerosis, Progressive Multiple Sclerosis

Start: 2021-08-09End: 2027-03-15Updated: 2026-03-12

Mesenchymal Stem Cells for Chronic Kidney Diseases

Not yet recruitingNCT07240987

The First Affiliated Hospital of Air Force Medicial UniversityDiabetic Kidney Disease (DKD), Hypertensive Nephropathy, Kidney Disease, Chronic

Start: 2026-01-01End: 2027-08-31Target: 32Updated: 2025-12-24

Phase 2

Peripheral Blood Stem Cell Combined With Mesenchymal Stem Cells for Treatment of Poor Graft Function

Nanfang Hospital, Southern Medical UniversityHematological Diseases, Poor Graft Function, Stem Cell Transplantation, Hematopoietic

Start: 2014-01-31End: 2017-01-31Target: 120Updated: 2014-03-11

MSC for Treatment of CMV Infection

Nanfang Hospital, Southern Medical UniversityCMV Infection, Hematological Diseases, Stem Cell Transplantation, Hematopoietic

Start: 2014-01-31End: 2017-01-31Target: 120Updated: 2015-01-07

MSCs With or Without Peripheral Blood Stem Cell for Treatment of Poor Graft Function and Delayed Platelet Engraftment

Nanfang Hospital, Southern Medical UniversityDelayed Platelet Engraftment, Hematological Diseases, Poor Graft Function +1

Start: 2014-09-30End: 2018-12-31Target: 120Updated: 2014-09-16

MSCs Combined With CD25 Monoclonal Antibody and Calcineurin Inhibitors for Treatment of Steroid-resistant aGVHD

Nanfang Hospital, Southern Medical UniversityAcute Graft-versus-host Disease

Start: 2014-09-30End: 2018-12-31Target: 200Updated: 2014-09-16

MSC Administration for the Management of Type 1 Diabetic Patients

Universidad del DesarrolloType 1 Diabetes Mellitus

Start: 2012-03-31End: 2017-03-31Updated: 2016-09-08

MSC for Severe aGVHD

Fujian Medical UniversitySteroid-resistant Severe aGVHD

Start: 2017-12-01End: 2021-12-01Target: 50Updated: 2018-08-15

Autologous Stem Cell Therapy in Patients With Multiple System Atrophy

Not yet recruitingNCT07465198

Biocells MedicalMSA, MSA - Multiple System Atrophy

Start: 2026-09-01End: 2031-03-01Target: 50Updated: 2026-03-11

Unknown Phase

Role of Stem Cells, Platelet Rich Plasma in Treatment of Scars

CompletedNCT03264573

Heba Mohamed Saad EldienAtrophic Scar

Start: 2016-07-31End: 2017-07-31Updated: 2017-08-29

Related Papers

Reduced morbidity and mortality of cGVHD in patients who received treatment with mesenchymal stromal cells for steroid-resistant aGVHD: long-term follow-up of a randomized phase 3 trial.

2025-07-09

Efficacy and safety of Lenzumestrocel (Neuronata-R® inj.) in patients with amyotrophic lateral sclerosis (ALSUMMIT study): study protocol for a multicentre, randomized, double-blind, parallel-group, sham procedure-controlled, phase III trial

Trials2022-05-1815 citations

Mesenchymal stromal cells plus basiliximab, calcineurin inhibitor as treatment of steroid-resistant acute graft-versus-host disease: a multicenter, randomized, phase 3, open-label trial

Journal of Hematology & Oncology2022-03-0784 citations

Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial.

2021-02-10188 citations

Efficacy of Mesenchymal Stem Cells in Bronchiolitis Obliterans Syndrome after Allogeneic HSCT: A Multicenter Prospective Cohort Study

Blood2019-11-134 citations

The efficacy of mesenchymal stem cells in bronchiolitis obliterans syndrome after allogeneic HSCT: A multicenter prospective cohort study.

2019-10-2322 citations